The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback